Low oxygen tension (hypoxia) is a common feature of solid tumors and stimulates the expressions of a variety of genes including those related to angiogenesis, apoptosis and endoplasmic reticulum (ER) stress response. Here we show a close correlation between metastatic potential and the resistance to hypoxia-and ER stress-induced apoptosis among the cell lines with differing metastatic potential derived from Lewis lung carcinoma. An apoptosis-specific expression profiling and immunoblot analyses revealed that the expression of antiapoptotic Mcl-1 increased as the resistance to apoptosis increased. Downregulation of the Mcl-1 expression in the high-metastatic cells by Mcl-1 small interfering RNA increased the sensitivity to hypoxia-induced apoptosis and decreased the metastatic ability. The hypoxia-induced apoptosis was not associated with p53 accumulation, although at present it is not possible to conclude that apoptosis-induced apoptosis is p53-independent. There was no correlation between the expression levels of ER stress-response proteins GADD153, GRP78 and ORP150 and the resistance to hypoxia or ER stresses. In vitro, small numbers of the high-metastatic cells overtook the low-metastatic cells after exposure to several rounds of hypoxia and reoxygenation. In solid tumors initially established from equal mixtures, the proportion of the high-metastatic cells to low-metastatic cells was significantly higher in hypoxic areas. Moreover, the high-metastatic cells were overtaking the low-metastatic cells in some of the tumors. Thus, tumor hypoxia and ER stress may provide a physiological selective pressure for the expansion of the high-metastatic cells overexpressing Mcl-1 and exhibiting reduced apoptotic potential in solid tumors.
Introduction
Response to low oxygen tension (hypoxia) is a fundamental biological phenomenon and therefore hypoxia gives rise to a variety of physiological responses at cellular, local and systemic levels. The cells placed under hypoxic conditions activate many genes including those related to cell survival, glycolysis, angiogenesis, erythrocyte production and iron metabolism to adapt the environment (Semenza, 2000 (Semenza, , 2002 Harris, 2002) . The oxygen sensing mechanisms have been intensively studied and found to involve hypoxia-inducible factors (HIFs) as key regulatory transcription factors that are composed of HIF-a subunit and HIF-b/aryl hydrocarbon receptor nuclear translocator subunit (Semenza, 2000 (Semenza, , 2002 Harris, 2002) . HIF binds to the hypoxiaresponsive element of hypoxia-responsive genes such as vascular endothelial growth factor (VEGF) and proapoptotic Bnip3, a member of the Bcl-2 family (Semenza, 2000 (Semenza, , 2002 Harris, 2002) .
Most solid tumors harbor areas of hypoxia, both acute and chronic, due to aberrant vasculature formation and high interstitial pressure (Chaplin and Hill, 1995; Brown and Giaccia, 1998) . Although most of the tumor cells die in chronic hypoxia, some of them actually can survive for more than several days in a quiescent or the so-called dormant state (Durand and Sham, 1998) and restart to divide once closed vessels reopen or new vasculatures reach the hypoxic areas. It has been shown that hypoxia induces genetic instability, DNA over-replication and gene amplification in a variety of cultured cells (Rice et al., 1986; Russo et al., 1995; Coquelle et al., 1998) . A short-term hypoxia followed by reoxygenation transiently enhances invasive and metastatic potential of some tumor cells (Young and Hill, 1990; Graham et al., 1999; Cairns et al., 2001) . Tumor hypoxia selects p53 À/À transformed cells and thereby expands cells with diminished apoptotic potential in vitro (Graeber et al., 1996) . These mechanisms all together are likely to influence the malignant progression of tumor cells (Hill, 1990; Russo et al., 1995; Graeber et al., 1996; Coquelle et al., 1998; Dachs and Chaplin, 1998) . Besides, since hypoxic tumor cells cease to divide, they are resistant to conventional radiotherapy and chemotherapy (Rice et al., 1986; Young and Hill, 1990; Teicher, 1994) .
Physiological endoplasmic reticulum (ER) stress such as glucose starvation is also present in solid tumors. Hypoxia has been shown to upregulate ER stressresponse genes including growth arrest/DNA damageinducible protein 153 (GADD153/CHOP), which is a proapoptotic transcription factor (Friedman, 1996) and ER chaperones such as glucose-regulated protein (GRP)78/BIP (Munro and Pelham, 1986 ) and oxygenregulated protein (ORP)150, which are antiapoptotic proteins (Kuwabara et al., 1996) . Upregulation of these ER stress proteins is HIF-independent.
There is accumulating evidence that developing resistance to common apoptotic stimuli is one of the factors that confer high metastatic capability to tumor cells (Glinsky and Glinsky, 1996; McConkey et al., 1996; Bufalo et al., 1997; Glinsky, 1997; Inbal et al., 1997; Shtivelman, 1997; Takaoka et al., 1997; Fernandez et al., 2000; Lowe and Lin, 2000; Wong et al., 2001) . The apoptosis-resistant phenotype may be advantageous for tumor cells to survive in the metastatic process. We reported that the high-metastatic clone (A11 cells) established from Lewis lung carcinoma is more resistant to apoptosis induced by serum starvation, hypoxia and glucose deprivation than the low-metastatic clone (P29 cells) (Takasu et al., 1999) . However, it remained to be examined whether there is a correlation between metastatic ability and resistance to apoptosis induced by various stresses among various clones with differing metastatic potential. In addition, molecular mechanisms of the apoptosis resistance of the high-metastatic cells remained obscure. We addressed here these points and, furthermore, if hypoxia could act as a physiological selective pressure in solid tumors for the expansion of high-metastatic tumor cells that possess diminished apoptotic potential. The results showed that the highmetastatic Lewis lung carcinoma cell lines are more resistant to hypoxia-and ER stress-induced apoptosis than the low-metastatic cell lines, that the high-metastatic cells overexpress antiapoptotic Mcl-1, and that hypoxia selects for the high-metastatic cells in solid tumors.
Results
Correlation between metastatic potential and resistance to hypoxia-and ER stress-induced apoptosis in the low-and high-metastatic cell lines To investigate the correlation between susceptibility to hypoxia-induced cell death and metastatic potential, we exposed the five cell lines with differing metastatic potential derived from a mouse Lewis lung carcinoma (metastatic capability; P29 ¼ P34oC2oD6 oA11) to hypoxia (B0.1% O 2 ), corresponding to oxygen concentrations commonly found in solid tumors. Cell death was monitored after culturing the cell lines for 72 h under hypoxia. The results showed that only less than 8% of P29 and P34 cells were viable while about 20% of C2 cells and over 45% of D6 and A11 cells remained viable ( Figure 1a) . Thus, we observed a tendency where the resistance to hypoxia-induced cell death is correlated with the metastatic ability. The time course showed that hypoxia induced cell death more rapidly in P29 cells than in A11 cells (Figure 1b) . Clonogenic assays in which the cells were exposed to hypoxia for 3 or 4 days and then reoxygenated to form colonies also demonstrated that A11 cells survived longer than P29 cells under hypoxic conditions (Figure 1c ). The cells positive for annexin V and TUNEL staining increased in hypoxic P29 cells (Figure 1d ). An increase in the number of cells exhibiting chromatin condensation and fragmentation as assessed by DAPI staining was also observed in hypoxic P29 cells (0.1 and 26.1% for normoxic and hypoxic P29 cells, respectively) ( Figure 1d ). In addition, flow cytometric analysis revealed an increase in the percentage of sub-G1 population in these cells (0.7 and 20.6% for normoxic and hypoxic cells, respectively) (Figure 1e ). Thus, these data indicate that hypoxic P29 cells were dying through apoptosis. We confirmed that hypoxic A11 cells died of apoptosis based on the same criteria.
To test whether the high-metastatic cell lines are also resistant to ER stresses compared with the low-metastatic cell lines, we treated P29, P34, D6 and A11 cells with chemical ER stress inducers for 2 days and examined their viability. As shown in Figure 2 , compared to P29 and P34 cells, D6 and A11 cells were much more resistant to apoptosis induced by tunicamycin (5 mg/ml), brefeldin A (5 mg/ml), thapsigargin (250 nM) and A23187 (1 mM).
Mcl-1 is overexpressed in the high-metastatic cell lines To find out the genes responsible for the susceptibility to hypoxia-induced apoptosis, we compared the expression profile of apoptosis-related genes among normoxic and hypoxic P29 and A11 cells using a cDNA expression microarray cumulated apoptosis-related genes. The data showed that A11 cells expressed antiapoptotic Mcl-1 gene at higher levels than P29 cells (not shown). Immunoblot analysis confirmed a higher expression of Mcl-1 in A11 cells than in P29 cells under both normoxic and hypoxic conditions ( Figure 3A ). We detected two close bands (40 and 37 kDa) on the blots. Since the expressions of the bands were decreased by treatment with Mcl-1 siRNA (see below), the 37 kDa band may be a degradation product of Mcl-1 or, though less likely, a splicing variant of Mcl-1 gene. It is of note that the cell lines expressed Mcl-1 (40 kDa) at the levels according to the resistance to hypoxia-and other stressinduced apoptosis ( Figure 3A and B). Consistent with the recent report that hypoxia enhances Mcl-1 expression in hepatoma HepG2 cells through HIF-1 (Piret et al., 2005) , the amount of Mcl-1 was increased by hypoxia in C2, D6 and A11 cells ( Figure 3B ). Immunohistochemistry for Mcl-1 on the sections prepared from paraffin-embedded P29 and A11 tumors showed a higher expression of Mcl-1 in A11 cells than in P29 cells, indicating that Mcl-1 overexpression is persistent even in vivo ( Figure 3C ).
The expression profiling also showed that hypoxia induced proapoptotic Bnip3 gene expression in both P29 Hypoxia selects for high-metastatic cells N Koshikawa et al and A11 cells (data not shown). Actually, Bnip3 mRNA expression was induced in all of the cell lines, but the expression level was not correlated with the susceptibility to hypoxia-and other stress-induced apoptosis ( Figure 3D ).
To investigate whether the hypoxia-induced apoptosis is associated with p53 accumulation, we examined the expression of p53 in hypoxia-and doxorubicin-treated P29, P34, D6 and A11 cells. Immunoblot analysis revealed that hypoxia reduced p53 expression ( Figure 3E ) and failed to induce endogenous downstream p53 effector proteins, Bax and p21
, in these cell lines (not shown). By contrast, doxorubicin caused the accumulation of p53 ( Figure 3E ).
We next compared the expression levels of ER stressresponse proteins, GADD153, GRP78 and ORP150, which are known to be induced by hypoxia, between P29 and A11 cells. As shown in Figure 3F and G, the expressions of these proteins were induced by tunicamycin and hypoxia, but there was no difference between 29 and A11 cells.
Effects of Mcl-1 siRNA on hypoxia-induced apoptosis and metastatic potential To examine if the expression of Mcl-1 is responsible for the resistance to hypoxia-induced apoptosis, we transfected A11 cells with either Mcl-1 siRNA or control siRNA. As shown in Figure 4a and b, the expression of Mcl-1 was suppressed by Mcl-1 siRNA, but not by control siRNA. We then cultured these cells under hypoxic conditions for 60 h and monitored cell death. The results showed that Mcl-1 siRNA-treated A11 cells were more sensitive to hypoxia-induced apoptosis than mock and control siRNA-treated cells in both normal growth medium and serum-starved medium ( Figure 4c ). Importantly, Mcl-1 siRNA-treated A11 cells were less metastatic than control siRNAtreated cells, as assessed by lung weight and the number of metastatic nodules in the lung (Figure 4d ). Thus, it appeared that Mcl-1 is at least in part involved in resistance to hypoxia-induced apoptosis and metastatic potential of A11 cells.
Apoptosis of the low-and high-metastatic cells in hypoxic areas of solid tumors
To examine whether the difference in the susceptibility to hypoxia-induced apoptosis can also be observed in vivo, we injected EF5, a nitroimidazole compound, into mice bearing subcutaneous P29 or A11 tumors of nearly equal size for detecting hypoxic areas and stained cryosections of the tumors first with TUNEL assay using fluorescein-labeled nucleotides, and then with Cy3-labeled antibodies against EF5-cellular macromolecule adducts (Figure 5a ). EF5 binding occurs under low-oxygen conditions and only in viable cells (Lord et al., 1993) . The number of TUNEL-positive cells per 100 mm 2 in EF5-positive (hypoxic) and -negative (normoxic) areas was counted ( Figure 5b ). We omitted necrotic areas from the investigation. The results showed that the number of apoptotic cells in hypoxic areas of P29 tumors was fourfold larger than that in hypoxic areas of A11 tumors. In normoxic areas, the number of apoptotic cells was small but statistically larger in P29 tumors than in A11 tumors. and A11 cells () exposed to ER stress-inducing agents. The cells were exposed to tunicamycin (5 mg/ml), brefeldin A (5 mg/ml), thaspigargin (250 nM), A23187 (1 mM)). (b) Sensitivity of the cell lines with differing metastatic potential to ER stress-inducing agents. P29, P34, D6 and A11 cells were exposed to tunicamycin (5 mg/ml), brefeldin A (5 mg/ml), thaspigargin (250 nM), A23187 (1 mM)) for 2 days. Percentage of living cells was determined on the basis of trypan blue exclusion. Bars; s.d. of triplicate determinations. Western blot analysis of the effects of tunicamycin on the expressions of GADD153 and GRP78. P29 and A11 cells were exposed to 5 mg/ml tunicamycin for the indicated periods of time. bActin served as loading controls. (G) Western blot analysis of the effects of hypoxia on the expressions of GADD153, GRP78 and ORP150. P29 and A11 cells were exposed to hypoxia (0.1% O 2 ) for the indicated periods of time. b-actin served as loading controls.
Hypoxia selects for high-metastatic cells N Koshikawa et al high-metastatic, respectively, in both experimental and spontaneous metastasis assays ( Figure 6c ) and showed a similar apoptosis resistance to their parental cells (Figure 6d ). To obtain a standard curve by which the percentage of A11
IRES-EGFP cells in mixtures of unknown proportions of P29 EGFP and A11 IRES-EGFP cells could be calculated, we extracted genomic DNA from mixtures of known proportions of the cells and performed PCR followed by Southern blot with an EGFP probe (Figure 6e) . By plotting the relative intensities of the bands corresponding to EGFP and IRES-EGFP against the known proportion of A11 IRES-EGFP cells, a standard curve, although slightly sigmoid, was obtained (Figure 6f) . The value at each point did not significantly fluctuate even when we carried out PCR under various conditions (1-100 ng DNA, 20-35 PCR cycles) (not shown).
We then mixed A11 IRES-EGFP and P29 EGFP cells at a 1:1, 1:10 or 1:100 ratio and treated them with multiple rounds of hypoxia and reoxygenation (recovery in normoxia). The percentage of A11 IRES-EGFP cells at the time of cell harvesting was determined from the standard curve after quantitation of radioactive intensity of the PCR bands. We found that the percentage of A11 IRES-EGFP cells increased dramatically after several rounds of hypoxia-reoxygenation in every case ( Figure  7a and b) . The intensity of the band corresponding to EGFP and IRES-EGFP in P29
EGFP and A11
IRES-EGFP (Figure 6b ), the percentage of A11 IRES-EGFP cells in both normoxic and hypoxic areas of the heterogeneous tumors should be lower than 50% if no selection of cells occurs in the tumors. We cut out EF5-negative andpositive areas (approximately total 1 mm 2 ) from cryosections of the tumors excised at 17 days after tumor inoculation by using laser-assisted microdissection, extracted genomic DNA, and then examined the percentage of A11
IRES-EGFP cells in these areas as described above (Figure 8a and b) . The data showed that the proportion of A11
IRES-EGFP cells in normoxic areas decreased from the initial 50% in five out of the seven mixed tumors. However, the proportion was over 70% in #2 and #5 tumors (Figure 8b) (Figure 8d and e) . In #5 tumor, it was below 50%. This and the above results suggest that A11
IRES-EGFP IRES-EGFP cells was over 50% in #1 and #6 tumors, suggesting that the cells were overtaking P29 EGFP cells in these tumors. In other 3 tumors, the percentage was below 50%, indicating that selection of A11 IRES-EGFP cells was occurring in local hypoxic areas of these tumors but was not apparent in whole tumor mass.
Discussion
The data presented here showed a close correlation between metastatic potential and the resistance to hypoxia-induced apoptosis among the cell lines with differing metastatic potential. They also showed that the high-metastatic cells are more resistant to ER stressinduced apoptosis. The hypoxia-induced apoptosis may be p53-independent, because hypoxia neither caused p53 accumulation nor induced the expressions of endogenous downstream p53 effector proteins. An apoptosisspecific expression profiling and immunoblot analyses demonstrated a correlation between the resistance to hypoxia-induced apoptosis and the expression level of Mcl-1. Downregulation of the Mcl-1 expression in A11 cells by Mcl-1 siRNA increased the sensitivity to hypoxia-induced cell death and, importantly, decreased the metastatic ability. Although there are so far few reports directly indicating the involvement of Mcl-1 in metastatic potential of tumor cells, a clinicopathological study suggested Mcl-1 as an indicator of tumor progression and prognosis in patients with gastric carcinoma (Maeta et al., 2004) . Therefore, Mcl-1 may be one of the factors that confer metastatic potential on at least some tumor cells.
In agreement with the previous reports (Bruick, 2000; Guo et al, 2001) , hypoxia induced the expression of Bnip3 in all of the cell lines used in this study. Bnip3 is a mitochondrial protein and induces apoptosis independently of Apaf-1, cytochrome c release and caspase activation . Bcl-2 and Bcl-X L bind to Bnip3 and inhibit apoptosis caused by the overexpression of Bnip3 (Ray et al., 2000) . Therefore, it is possible that Mcl-1 binds to Bnip3 and inhibits Bnip3-induced apoptosis. We preliminarily examined this possibility, and the data showed that Mcl-1 physically interacts with Bnip3 (data not shown).
There was no difference in the inducibility of ER stress-and hypoxia-inducible genes such as GADD153, GRP78 and ORP150 genes between the low-and the high-metastatic cell lines, eliminating the involvement of these genes in the difference of the sensitivity to hypoxia-and ER-stress-induced apoptosis.
The present results clearly demonstrated the survival advantage of A11 cells over P29 cells. In the mixed culture, A11 cells overtook P29 cells during several rounds of hypoxia-reoxygenation. It would be of interest to note that as the rounds of selection proceeded A11 cells progressively became more resistant to apoptosis induced by not only hypoxia but also serum starvation, glucose deprivation and anticancer drugs such as cisplatin and etoposide (not shown). Therefore, it is likely that repeated exposure to hypoxia-reoxygenation results in the selection of not merely A11 cells with original phenotype but of A11 cells with more malignant phenotype, consistent with previous reports (Kim et al., 1997; Kinoshita et al., 2001) .
Coinciding with the in vitro experiments, the frequency of apoptosis was greater in the hypoxic areas of A11 tumors than in those of P29 tumors. Intriguingly, it appeared that A11 cells became a majority in the hypoxic areas of many tumor masses established from equal mixtures of P29 and A11 cells. It is of note that although we randomly excised the hypoxic areas the proportion of A11 cells in these areas was over 90% in Hypoxia selects for high-metastatic cells N Koshikawa et al several samples. This was somewhat surprising. We had expected that the proportion would vary widely from one sample to another, because the time of hypoxia influences the degree of apoptosis and EF5-binding does not tell us how long hypoxia had lasted in EF5-positive areas before excision. Nevertheless, a majority of P29 cells was commonly lost in the randomly selected hypoxic areas. One possible explanation for this is that P29 cells die more rapidly in in vivo hypoxic areas in which starvation of growth factors and nutrients that could act synergistically with hypoxia to induce apoptosis also occurs. We then exposed P29 and A11 cells to serum starvation (0.5% FBS) and hypoxia (0.1% O 2 ) simultaneously. The data showed that more than 75% of P29 cells died within 24 h while more than 70% of A11 cells survived. Thus, P29 cells are less tolerant towards severer conditions in in vivo hypoxic areas than A11 cells, and this might explain the rapid loss of P29 cells in hypoxic areas. Interestingly, we observed two cases out of the seven tumors in which A11 cells dominated in not only hypoxic areas but also normoxic areas. It is possible that the normoxic areas represent the ones that are reoxygenated after hypoxia. Intriguingly, in one case (#2 tumor), the proportion of A11 cells in the tumor mass was over 90%. This suggests that a majority of P29 cells died of apoptosis induced by severe hypoxia and other microenvironmental factors in the early phase of growth of this tumor, resulting in the selection of A11 cells. The degree of tumor vascularization and angiogenesis may vary from one tumor to another even if they are established from the same tumor cells, and accordingly the extent of hypoxia may differ in individual tumor. This may explain the difference in the proportion of A11 cells in each tumor. It has been reported that hypoxia induces p53-dependent apoptosis and thus selects p53 À/À cells (Graeber et al., 1996) . Our study showed that hypoxia selects for cells with reduced apoptotic potential and high-metastatic ability. This phenomenon could occur in human tumors such as cervical cancer, head and neck cancer and soft tissue sarcoma in which a correlation between hypoxia and aggressiveness or poor prognosis has been reported (Brizel et al., 1996, 1997; Ho¨ckel al., 1996, 1999) . Therefore, the data presented here may have important implications for malignant progression of tumors.
Materials and methods

Cell culture
The cell lines, P29, P34, C2, D6 and A11, established from Lewis lung carcinoma, have been characterized elsewhere (Takasu et al., 1999; Koshikawa et al., 2003) . They were grown in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum supplemented with 100 units/ml penicillin and 100 mg/ml streptomycin. Cells were cultured at 371C in a humidified atmosphere with 5% CO 2 or under hypoxic conditions (ca. 0.1% O 2 ) generated in BBL GasPak Pouch (Becton Dickinson Microbiology Systems, Cockeysville, MA, USA). In some experiments, they were treated with tunicamycin (Sigma-Aldrich, St Louis, MO, USA), brefeldin A (WAKO Pure Chemical Industries, Ltd., Osaka, Japan), thapsigargin (Sigma-Aldrich), A23187 (Sigma-Aldrich) or vehicle alone.
Assessment of cell viability and apoptosis
Cells were seeded at a concentration of 3 Â 10 5 cells/dish (Falcon 3002), and cell death was induced by culturing them under hypoxic conditions or in the presence of various drugs. For aerobic recovery, the cells were cultured in normoxia until they become subconfluent, thus the recovery time was different for each cell line. Cell viability was assessed by trypan blue dye exclusion. Flow cytometric analysis was performed as described previously (Takasu et al., 1999) to detect cellular DNA fragmentation with a FACScan flow cytometer (Becton Dickinson, Mountain View, CA, USA). Chromatin condensation and fragmentation were visualized by staining the cells with DAPI (10 mg/ml). Annexin V and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling (TUNEL) stainings were carried out using Annexin V-EGFP Apoptosis Detection Kit (MBL, Nagoya, Japan) and ApopTag Fluorescein In situ Apoptosis Detection Kit (Serologicals Corp., Norcross, GA, USA), respectively, according to the manufacturer's instructions. The fluorescence was observed under a Fluoview confocal laser microscope (Olympus, Tokyo, Japan). For clonogenic assay, cells were seeded at a concentration of 100 cells/well of six-well plates (Falcon 3046), incubated for 3 or 4 days under hypoxic (B0.1% O 2 ) conditions, and then allowed to grow under normoxic conditions for 8-10 days. Colonies were fixed with methanol and stained with 0.05% crystal violet.
Expression profiling of apoptosis-related genes Expressions of apoptosis-related genes in normoxic and hypoxic P29 and A11 cells were carried out using Mouse Apoptosis GEArray Qt series containing a panel of 96 key genes involved in apoptosis (SuperArray, Inc., Bethesda, MD, USA). Hybridization of the microarray with a biotin-16-dUTP-labeled cDNA probe and chemiluminescent detection were performed according to the manufacturer's instructions.
Northern blot analysis
Total RNA was electrophoresed on 1% agarose gel containing formaldehyde and transferred to nylon filters. Blots were hybridized with a 32 P-labeled mouse Bnip3 cDNA probe that was prepared by RT-PCR.
Small interfering RNA (siRNA) transfection
Mcl-1 siRNA (Santa Cruz Biotechnologies, Inc., Santa Cruz, CA, USA) or Silencer Negative Control #1 siRNA (Ambion, Inc., Austin, TX, USA) was transfected into A11 cells with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. At 3 days after transfection, the cells were subjected to immunoblot analysis for Mcl-1 expression, apoptosis assay and metastasis assay.
Immunoblot analysis
Cells were lysed in 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM PMSF and protease inhibitor cocktail (Sigma-Aldrich) or directly dissolved in SDS sample buffer. After centrifugation at 10 000 g for 10 min at 41C, the supernatant was used for immunoblot analysis. Proteins were separated by SDS-PAGE under reducing conditions and transferred to a nitrocellulose membrane. The membrane was incubated with first antibodies, washed extensively with TBS-T, and then with speciesappropriate HRP-conjugated secondary antibodies. The first antibodies used were anti-p53 antibody (Ab-3, CalbiochemNovabiochem, Germany), anti-Mcl-1 antibody (Santa Cruz Biotechnology, Inc.), anti-GADD153 antibody (Santa Cruz Biotechnology, Inc.), anti-GRP78 antibody (Santa Cruz Biotechnology, Inc.), anti-ORP180 antibody (IBL, Fujioka, Japan) and anti-b-actin antibody (Sigma-Aldrich). Immunodetection was performed using the enhanced chemiluminescence system (ECL; Amersham Biosciences Corp., Piscataway, NJ, USA). The image of the bands was acquired with an imaging densitometer, and the signal intensities were analyzed with an NIH Image 1.63 software on a Machintosh computer. All signals were normalized to b-actin.
Tumor growth and metastasis assays Cells (2 Â 10 5 cells/mouse) were inoculated into the abdominal flank of age-matched female C57BL/6 mice (Nippon SLC, Hamamatsu, Japan). Subcutaneous tumor growth was monitored by caliper measurement of two diameters at right angles, and the tumor mass was estimated from the equation
, where a and b are the larger and smaller diameters, respectively. For spontaneous metastasis assay, the mice were killed 30 days after tumor cell inoculation, and their lungs were removed. For experimental metastasis assay, tumor cells (2 Â 10 5 cells/mouse) were injected intravenously, and the lungs were removed 17 days later. The lungs were fixed in Bouin's solution and the parietal metastatic nodules were counted. All animal experiments were performed in compliance with the institutional guidelines for the care and use of laboratory animals.
Immunohistochemistry
Subcutaneous tumors were excised, fixed in 10% buffered formalin and embedded in paraffin wax. Paraffin sections were cut at 6 mm thickness and mounted on the silane-coated glass slides. After routine dewaxing and rehydrating, the sections were incubated in 1 Â ChemMate s Target Retrieval Solution (DakoCytomation, Glostrup, Denmark) at 1211C for 15 min and rinsed with Dulbecco's phosphate-buffered saline (DPBS). For quenching endogenous peroxidase activity, the sections were incubated in 0.3% H 2 O 2 in methanol for 30 min. Thereafter, they were incubated with diluted normal goat serum for 20 min at room temperature and then incubated with anti-Mcl-1 antibody or normal rabbit IgG (4 mg/ml) diluted in ChemMate s Antibody Diluent (DaKoCytomation) containing 2% dry milk at 41C for 16 h. Immunostaining was carried out by using VECTASTAIN 
Detection and microdissection of hypoxic areas in tumors
In all, 300 ml of EF5 solution (3 mg/ml) was injected intraperitoneally into mice bearing subcutaneous tumors (Inbal et al., 1997) . After 1 h, tumors were surgically removed and frozen in OCT compound. Cryostat sections cut at 10 mm were fixed with 4% paraformaldehyde and washed with DPBS. The sections were treated with 5% mouse serum, 20% dry milk and 0.3% Tween 20 in DPBS overnight at 41C to block nonspecific binding sites. They were rinsed with 0.3% Tween 20 in DPBS and then incubated with Cy3-labeled monoclonal anti-EF5 antibody (ELK3-51) for 4 h at 41C. After extensive washing with DPBS, tissue samples were observed under a confocal laser microscope or a fluorescence microscope. For detection of apoptotic cells in vivo, TUNEL staining was performed followed by EF5 staining. In some experiments, EF5 binding-positive (hypoxic) and adjacent EF5 binding-negative (normoxic) areas in tumor tissues were dissected using a laser-assisted microdissection system (Leica Microsystems, Tokyo, Japan).
Establishment of cells transfected with pEGFP-N1 or pIRES2-EGFP plasmid P29 and A11 cells were transfected with pEGFP-N1 and pIRES2-EGFP (BD Biosciences Clontech, Tokyo, Japan), respectively, using Lipofectin reagent (Invitrogen, Tokyo, Japan). After selecting the transfected P29 or A11 cells in the presence of 800 mg/ml G418, a clone designated P29 EGFP or A11 IRES-EGFP , respectively, was established. They were routinely cultured in the presence of 400 mg/ml G418.
DNA isolation, PCR and Southern blotting
Genomic DNA was extracted from P29 EGFP , A11
IRES-EGFP , mixed cells, solid tumors or microdissected sections by conventional method, treated with RNase A (10 mg/ml) and phenol extracted again. PCR was performed using 1-100 ng genomic DNA and rTaq DNA polymerase (TOYOBO Biochemicals, Osaka, Japan) on a Perkin Elmer GeneAmp PCR System 9700. The sense primer (P1) was 5 0 -AAC TCCGCCCCATTGACGC-3 0 corresponding to the sequence within the CMV promoter, and the antisense primer (P2) was 5 0 -ACAAACCACAACTAGAATGCAG-3 0 corresponding to the sequence in the SV40polyA signal. These primers were designed to amplify the EGFP sequence in pEGFP-N1 plasmid and the IRES-EGFP sequence in pIRES2-EGFP plasmid, thus yielding 1118 and 1693 bp PCR products, respectively. The PCR conditions were 941C for 3 min, followed by 20-30 cycles of 941C for 30 s, 551C for 30 s and 721C for 1 min. The resulting PCR products were electrophoresed on 1.2% agarose gels, transferred to nylon membranes and hybridized with a 32 P-labeled EGFP cDNA. The membranes were washed and radioactive intensity corresponding to the EGFP and IRES-EGFP bands was quantitated using a Fluoro Image Analyzer FLA-5000 (FUJIFILM, Tokyo, Japan). The measured percentage of A11 IRES-EGFP cells was determined by dividing the intensity of the IRES-EGFP band by the total intensity of the EGFP plus IRES-EGFP bands. The actual percentage of A11
IRES-EGFP cells in a mixed culture and in a tumor was determined from a standard curve established from Figure 6f .
